CCPP Module 11, Section 3: Enrollment, Consent, and Care Coordination Processes
MODULE 11: PATIENT IDENTIFICATION AND RISK STRATIFICATION

Section 11.3: Enrollment, Consent, and Care Coordination Processes

From First Contact to Seamless Collaboration: The Operational Blueprint for Your Clinical Service.

SECTION 11.3

Enrollment, Consent, and Care Coordination Processes

Master the practical workflows for enrolling patients into your service, obtaining proper consent, and establishing clear communication channels with the rest of the care team.

11.3.1 The “Why”: Building the Foundation of Trust and Legitimacy

The preceding sections have equipped you with the analytical skills to identify where your expertise is most needed. You have learned to pinpoint high-risk disease states and use data to stratify entire patient populations, focusing your attention on the most vulnerable. You have, in essence, created a highly qualified list of candidates for your clinical services. But this is where the abstract world of data analytics ends and the tangible, complex world of human interaction begins. A list of names in an EHR registry is not a clinical service. The process of transforming that list into a panel of engaged, consented patients under your active management is the most critical operational challenge you will face.

This transformation is not a mere administrative formality; it is the very foundation upon which the trust, legitimacy, and success of your entire practice is built. Without a robust, standardized, and patient-centered process for enrollment, consent, and care coordination, even the most brilliant clinical interventions will fail. A haphazard approach breeds confusion for patients, mistrust among provider colleagues, and legal and regulatory risk for your organization. Conversely, a well-architected process accomplishes three critical objectives:

  1. For the Patient: It establishes a clear, transparent, and respectful relationship. It ensures they understand who you are, what you are offering, and what they can expect. It empowers them to become active partners in their care through the bedrock principle of informed consent.
  2. For the Care Team: It demonstrates professionalism and defines your role within the larger clinical ecosystem. A clear process for communication and documentation signals that you are an integrated team member, not an isolated silo, fostering the collaborative relationships necessary for your success.
  3. For the Organization: It creates a legally defensible and auditable record of your practice. It ensures compliance with privacy laws, scope of practice regulations, and billing requirements. A documented, standardized process is your ultimate shield against liability and your strongest argument for the value and legitimacy of your service.

Think of this section as the architectural blueprint for the “front door” of your clinical practice. How you design this entryway determines whether patients and providers feel welcomed, confident, and secure in the care you provide. It is the essential, non-negotiable groundwork that must be laid before a single medication can be adjusted or prescribed under your authority.

Pharmacist Analogy: The Specialty Medication Onboarding Workflow

A new patient, anxious and overwhelmed, brings you a prescription for a complex, high-cost specialty medication like a PCSK9 inhibitor or a biologic for rheumatoid arthritis. Your pharmacy workflow for this scenario is a perfect parallel to the process of enrolling a patient into a CPA service.

You don’t just “fill the prescription.” You initiate a comprehensive onboarding process:

  • 1. Intake & Verification (Enrollment): You don’t just scan the bottle. You conduct a detailed intake. You create a comprehensive patient profile, verify their address, phone number, and critically, their insurance details. You confirm the diagnosis code and clinical rationale with the prescriber’s office. This is the enrollment phase—gathering all necessary information to officially bring them into your pharmacy’s high-touch service model.
  • 2. Financial Counseling & Consent (Consent): You run a test claim and discover the medication requires a prior authorization and the copay will be $350. You don’t proceed. You call the patient and have a detailed conversation. You explain the clinical benefits, the potential side effects, the administrative hurdles (the PA), and the exact out-of-pocket cost. You discuss manufacturer copay cards and foundation assistance. Only after the patient fully understands and verbally agrees to proceed do you move forward. This is informed consent—ensuring the patient is a willing and knowledgeable participant.
  • 3. Multi-Channel Communication (Care Coordination): The onboarding process now involves a flurry of coordinated communication. You send a prior authorization request to the insurance company. You send a message to the doctor’s office requesting supporting clinical notes. You call the patient back to give them a status update. Once approved, you coordinate the shipment of the medication from your specialty supplier and schedule a time with the patient for injection training. You are acting as the central communication hub, coordinating between the patient, the provider, and the payer.

This meticulous, multi-step process is second nature to you in the context of dispensing a high-risk drug. The process of enrolling a patient into your cognitive services requires the exact same level of rigor, professionalism, and documentation. The “product” is now your clinical expertise, but the principles of intake, consent, and coordination are identical.

11.3.2 Deep Dive: Mastering the Art of Patient Enrollment

Enrollment is the process of moving a patient from being an “identified name on a list” to an “active participant in your service.” This transition requires a thoughtful, patient-centered approach. The initial outreach and the first formal enrollment visit are critical moments that set the tone for your entire therapeutic relationship. A clumsy, confusing, or overly clinical introduction can cause a patient to decline the service, while a warm, clear, and benefit-oriented approach can create an enthusiastic partner in care.

The First Contact: Choosing Your Outreach Strategy

How you first approach a potential patient is a critical strategic decision. There are three primary methods, each with distinct advantages and disadvantages. Often, a successful program will use a blend of all three.

Masterclass Table: Patient Outreach & Recruitment Methods
Method Description Pros Cons Pharmacist Script Example
1. The “Warm Handoff” This is the gold standard. At the end of a visit with the primary care provider (PCP), the provider identifies the patient as a good candidate and personally introduces you. “Mrs. Smith, I’d like you to meet Sarah, our clinical pharmacist. She’s an expert on managing diabetes medications, and she’ll be working closely with you to help get your blood sugar under control.”
  • Extremely high enrollment rate (>90%)
  • Immediately establishes trust and legitimacy through the PCP’s endorsement
  • Allows for immediate, face-to-face rapport building
  • Highly dependent on provider memory and workflow
  • Difficult to scale; limited to patients who happen to have appointments
  • Requires you to be physically present in the clinic
(After PCP intro) “Hi Mrs. Smith, it’s so nice to meet you. Dr. Jones is right, I work with many of his patients to really focus on their medications. My goal is to make sure you’re on the best combination of medicines for you, that you’re not having any side effects, and that they’re affordable. We’d start with a one-on-one visit, just you and me, to go over everything. Would you be open to that?”
2. The Provider Referral The PCP places a formal referral or order in the EHR for “Clinical Pharmacist Services” after seeing a patient. You then receive this referral in your inbox and are responsible for contacting the patient to schedule their first visit.
  • Creates a formal, trackable record of the request
  • Still carries the weight of the provider’s recommendation
  • Allows you to manage your own schedule and outreach workflow
  • Patient may have forgotten the conversation with the PCP by the time you call
  • Lower enrollment rate than a warm handoff (60-80%)
  • Can create a backlog of referrals if not managed efficiently
“Hi, may I speak with Mrs. Smith? Hi Mrs. Smith, my name is Sarah, and I’m a clinical pharmacist here at the clinic. I’m calling because Dr. Jones sent me a referral to work with you. When you saw him last week, he mentioned he’d like me to help you with your diabetes medications. Do you recall that conversation? My role is to partner with you and Dr. Jones to really fine-tune your regimen. Would you have some time next week for an initial visit with me?”
3. Data-Driven “Cold” Outreach Using your EHR registries, you identify a high-risk patient who may not have had a recent visit. You contact them directly, referencing their provider and their health condition, to offer your services. This is often done via phone call or a secure patient portal message.
  • Highly scalable; allows you to reach the highest-risk patients systematically
  • Proactive; doesn’t rely on the patient having an appointment
  • Demonstrates the value of population health analytics
  • Lowest enrollment rate (can be <25%)
  • Patient may be confused or suspicious of the outreach
  • Requires excellent communication skills to quickly build rapport and explain your role
“Hi Mrs. Smith, my name is Sarah, I’m a clinical pharmacist on Dr. Jones’s team at the Community Clinic. The reason I’m calling is that our system helps us identify patients of Dr. Jones who are managing multiple medications for their heart failure, and your name came up as someone we should connect with. My role is to work with patients like you to simplify your medication routine and make sure it’s working as well as it can. There’s no cost for this service. Is this something you might be interested in learning more about?”
The Pharmacist’s Enrollment Visit Playbook

The first enrollment visit is a structured conversation designed to build rapport, explain your value, obtain consent, and set expectations. It is not a full clinical assessment. Follow this checklist:

  1. Introductions and Rapport-Building: Start with a warm greeting. “It’s so great to meet you. Dr. Jones has told me a lot about you.” Ask an open-ended, non-medical question to break the ice.
  2. The Patient-Centered “Elevator Pitch”: Clearly and simply explain who you are and what you do, focusing on the benefits to the patient. Avoid jargon. “My entire job is to be your personal medication expert. I’ll work with you to make sure your medicines are safe, easy to take, and doing what they’re supposed to do.”
  3. Confirm Their Understanding (Teach-Back): Ask the patient to explain your role back to you in their own words. “Just to make sure I’ve explained this well, could you tell me what you understand my role to be?”
  4. Review Goals of Care: Ask the patient what they want to get out of their healthcare. “What’s the most frustrating thing for you right now when it comes to your health or your medications?” Align your service with their stated goals.
  5. Explain the Process: Outline what they can expect. “Our first full visit will be about an hour. We’ll go through every single medication you take, including vitamins and over-the-counter products. After that, we’ll create a plan together, and I’ll share it with Dr. Jones. We’ll then have shorter check-ins as needed.”
  6. Obtain Formal Consent: This is a critical step, which we will detail in the next section. Review the consent form with them point-by-point.
  7. Schedule the First Clinical Visit: Book the first comprehensive medication management (CMM) appointment before they leave. This creates commitment and momentum.

11.3.3 Deep Dive: The Sanctity of Informed Consent

Informed consent is the ethical and legal cornerstone of modern medicine. It is a process, not just a signature on a form. It represents a dialogue wherein a patient is given all the relevant information about a proposed treatment or service—including its benefits, risks, and alternatives—and voluntarily agrees to participate. For a pharmacist practicing under a CPA, where you will be making decisions that directly alter a patient’s medication regimen, a meticulous and well-documented informed consent process is not optional; it is an absolute requirement.

It is critical to understand that the general “consent to treat” that a patient signs when they join a medical practice does not typically cover the specific activities you will be performing under a CPA. Your service—where a non-physician provider will be initiating, adjusting, and discontinuing prescription medications—is a distinct clinical service that requires its own specific consent. Failure to obtain and document this specific consent can open you and your organization to significant legal liability and is a major breach of professional ethics.

Verbal Consent is Not Enough: The Documentation Imperative

A patient verbally agreeing to “talk with the pharmacist” is not informed consent for a CPA service. The legal and professional standard requires a written consent form that is signed and dated by the patient (or their legal representative) and stored permanently in their medical record. The conversation you have with the patient is the process of consent, but the signed form is the proof of consent. In the unfortunate event of a negative outcome or a patient complaint, the adage “if it wasn’t documented, it wasn’t done” applies with full force. A signed consent form is your single most important piece of legal protection.

Masterclass Table: Anatomy of an Ironclad CPA Consent Form
Section of the Form What it Must Clearly State (in plain language) Why It’s Legally & Ethically Critical
1. Introduction of Service & Provider Clearly identifies you by name and title (e.g., “Sarah Jones, PharmD, Clinical Pharmacist”). Explains that you are part of their care team but are not their physician. Describes the name of the service (e.g., “Medication Management Service”). Prevents confusion about your role. Establishes that you are a qualified provider operating as part of the established care team.
2. Purpose & Goals of the Service Describes the goals of the service in patient-centered terms (e.g., “to help you get the most benefit from your medications,” “to prevent side effects,” “to help you reach your blood pressure goals”). Aligns the service with the patient’s own health objectives. This is the “benefit” part of the risk/benefit discussion.
3. Scope of Pharmacist’s Authority (The Core of the CPA) This is the most critical section. It must explicitly state what you are authorized to do. Example wording: “By signing this form, you give our clinical pharmacist permission to:
  • Start new medications.
  • Stop existing medications.
  • Change the doses of your medications.
  • Order lab tests to monitor your medications.
All of these actions will be done following a detailed protocol approved by your doctor.”
This is the explicit authorization for you to practice under the CPA for this specific patient. It is the legal nexus of the entire agreement. Ambiguity here is unacceptable.
4. Communication & Collaboration Explains that you will be in constant communication with their physician. “The pharmacist will share notes from every visit with your primary doctor. Your doctor is still in charge of your overall care.” It should also state how you will communicate with the patient (e.g., phone calls, secure portal messages). Reassures the patient that their physician is still involved and that care is coordinated. It sets expectations for how communication will occur.
5. Voluntary Participation & Right to Withdraw Must contain clear, unequivocal language stating that participation is completely voluntary and that their decision will not affect the quality of care they receive from their physician. It must also state that they can withdraw from the service at any time for any reason by simply telling a member of the care team. This is a fundamental patient right. It eliminates any perception of coercion and empowers the patient to control their own participation in the service.
6. Patient Acknowledgement A statement such as, “I have read this form (or had it read to me), I have had the chance to ask questions, and all my questions have been answered to my satisfaction. I voluntarily agree to participate in this Medication Management Service.” Confirms that the consent process (the dialogue) has occurred and that the patient feels adequately informed.
7. Signatures & Dates Lines for the patient’s printed name, signature, and date. A line for the witness’s (often you or another staff member) signature and date. If a legal representative is signing, there must be a section to document their name and relationship to the patient. The signed and dated form is the legal artifact that memorializes the consent agreement. It is the auditable proof that the process was completed.

11.3.4 Deep Dive: Architecting Seamless Care Coordination

You have successfully enrolled and consented your patient. You are now officially their medication expert. However, your effectiveness and your value to the team now hinge entirely on your ability to integrate your work into the overall care plan. Care coordination is the active and deliberate process of ensuring that all members of the care team—including the patient—are aware of your assessment, your plan, and any actions you have taken. Operating in a silo is not just inefficient; it is dangerous. Seamless communication is the lifeblood of collaborative practice.

The EHR is your primary tool for care coordination. Your documentation must be clear, concise, and targeted to the right audience. Your communication must be timely and actionable. You need to develop standardized workflows for different types of communication, from routine documentation of a visit to urgent escalation of a critical lab value.

Masterclass Table: Communication Protocols for the Collaborative Team
Scenario Primary Audience Recommended Method Content & Style of Message Pharmacist’s Goal
Documenting an initial CMM visit or routine follow-up Primary Provider, Nursing Staff, other specialists A formal progress note in the EHR, linked to the patient’s chart. Use a standard SOAP note format (Subjective, Objective, Assessment, Plan). Be comprehensive but concise. List medication-related problems and your specific plan for each. End with a clear statement of your follow-up plan. (See Insight Box below for a template). To create a comprehensive, permanent record of your assessment and plan. To allow other providers to quickly understand your thought process and intended actions.
Making a dose change or starting a new med per protocol Primary Provider (for awareness) A brief, targeted EHR message or “encounter to be co-signed,” depending on institutional policy. “FYI” style. “Per protocol, I have increased Mr. Smith’s lisinopril to 20 mg daily for persistent hypertension (latest BP 152/94). Will re-check BP in 2 weeks and monitor renal function. No co-signature needed unless you disagree.” To inform the PCP of an action you have taken under your delegated authority. This is about closing the communication loop, not asking for permission.
Recommending a change that is OUTSIDE your protocol Primary Provider (for permission) A formal EHR message requiring a response or a new order. Clear, concise, and actionable recommendation. “Mr. Smith’s A1c remains elevated at 8.8% despite max-dose metformin. Per guidelines, an SGLT2i would be a good next step for cardiorenal benefit. Would you like to order empagliflozin 10 mg daily? I can send the Rx to the pharmacy if you agree.” To use your clinical expertise to make a recommendation that requires the PCP’s formal sign-off, making it easy for them to agree and act.
Urgent/Critical Finding (e.g., severe hyperkalemia, INR of 9.0) Primary Provider (IMMEDIATELY) Direct phone call or page. Followed by EHR documentation of the call. Email/EHR message is NOT sufficient for urgent issues. “Dr. Jones, this is Sarah the pharmacist calling about your patient, John Smith. His routine lab check today shows a potassium of 6.5. I have reviewed his medications and recommend holding his lisinopril and spironolactone immediately. What are your instructions for further management?” To escalate a patient safety issue immediately to the responsible provider and receive real-time instructions, while simultaneously documenting the event.
The Perfect Pharmacist Progress Note: A CMM SOAP Template

Your documentation is your currency. A well-written note demonstrates your value and makes it easy for others to understand your contribution. Use this template:

  • Subjective: Patient’s report. How are they feeling? Any side effects? Adherence issues? What are their goals?
  • Objective: Hard data. Vitals (BP, HR), pertinent lab results (A1c, K+, SCr), weight.
  • Medication List: A fully reconciled, accurate list of all medications, including dose, route, frequency.
  • Assessment & Plan (by Medication-Related Problem): This is the heart of your note.
    • Problem 1: Uncontrolled Hypertension. A: BP remains above goal despite max-dose lisinopril. P: Per protocol, will add amlodipine 5 mg daily. Will provide patient education on potential side effects (edema). Will re-check BP in 2 weeks.
    • Problem 2: Statin Adherence. A: Patient reports only taking atorvastatin “a few times a week” due to cost. P: Switched patient to formulary-preferred, lower-cost rosuvastatin. Set patient up with 90-day mail order supply to reduce copays further. Provided adherence counseling.
    • Problem 3: Fall Risk. A: Patient reports dizziness upon standing. Taking multiple BP agents and nightly zolpidem. P: Educated patient on orthostatic hypotension precautions. Sent recommendation to PCP to consider tapering zolpidem, as it is on the Beers List and contributing to fall risk.
  • Follow-Up: State your plan clearly. “Will follow up with patient via telephone in 2 weeks to assess BP response and medication tolerance. Next scheduled CMM visit in 3 months.”